<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Physiology</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Physiology</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский физиологический журнал им. И.М. Сеченова</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0869-8139</issn><issn publication-format="electronic">2658-655X</issn><publisher><publisher-name xml:lang="en">The Russian Academy of Sciences</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">651623</article-id><article-id pub-id-type="doi">10.31857/S0869813924080022</article-id><article-id pub-id-type="edn">BCRJTF</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>EXPERIMENTAL ARTICLES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ЭКСПЕРИМЕНТАЛЬНЫЕ СТАТЬИ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Intranasal administration of GRP78 protein (HSPA5) counteracts the neurodegeneration in the locus coeruleus in a model of chronic sleep restriction in rats</article-title><trans-title-group xml:lang="ru"><trans-title>Интраназальное введение белка GRP78 (HSPA5) противодействует гибели нейронов в голубом пятне в модели хронической депривации сна у крыс</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Pazi</surname><given-names>M. B.</given-names></name><name xml:lang="ru"><surname>Пази</surname><given-names>М. Б.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pazimariia@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Ekimova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Екимова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>pazimariia@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov Institute of Evolutionary Physiology and Biochemistry of the Russian Academy of Sciences</institution></aff><aff><institution xml:lang="ru">Институт эволюционной физиологии и биохимии им. И. М. Сеченова РАН</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2024-08-15" publication-format="electronic"><day>15</day><month>08</month><year>2024</year></pub-date><volume>110</volume><issue>8</issue><issue-title xml:lang="ru"/><fpage>1238</fpage><lpage>1252</lpage><history><date date-type="received" iso-8601-date="2025-02-01"><day>01</day><month>02</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Russian Academy of Sciences</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Российская академия наук</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Russian Academy of Sciences</copyright-holder><copyright-holder xml:lang="ru">Российская академия наук</copyright-holder></permissions><self-uri xlink:href="https://journals.eco-vector.com/0869-8139/article/view/651623">https://journals.eco-vector.com/0869-8139/article/view/651623</self-uri><abstract xml:lang="en"><p>Chronic sleep restriction (sleep less than 6 hours per day) due to the workload and a decrease in sleep quality is an endemic disease in modern society. Chronic sleep deprivation causes serious neuropsychiatric disorders associated with irreversible neurodegenerative changes in the brain. The search for pharmacological agents that can reduce the risk of neurodegeneration as a result of chronic sleep loss is an urgent task issue for biomedicine. Intranasal administration of glucose-regulated 78 kDa heat shock protein (GRP78) has a neuroprotective effect in a rat model of Parkinson´s disease. The neuroprotective potential of intranasally administered GRP78 in chronic sleep deprivation has not been previously studied. The aim of the study is to find out whether preventive intranasal administration of GRP78 is able to weaken and/or stop the process of neurodegeneration in the locus coeruleus in the model of chronic sleep restriction (SR) in rats. The study was conducted on 6 months old male Wistar rats. For sleep deprivation, a validated method of a swinging platform was used in the mode: 3 hours of sleep deprivation and 1 hour of rest continuously for 5 days. Recombinant human protein GRP78 was administered intranasally two days before the start of SR and during 5 days of SR. Cellular and molecular changes in the locus coeruleus during SR and during the administration of GRP78 were studied using immunohistochemistry and Western blotting. It was shown that chronic SR leads to the degeneration of 30% of noradrenergic neurons in the locus coeruleus, that was associated with an increase in the levels of activated caspases-3 and 9. This indicates the development of apoptosis along the mitochondrial pathway. No signs of reactive microgliosis were found in the model of chronic SR in rats. We have demonstrated that intranasally administered GRP78 penetrates and accumulates in the neurons of the locus coeruleus, GRP78 counteracts the death of neurons along the path of apoptosis. The data obtained allows to consider GRP78 as a potential neuroprotective agent for the prevention of pathological consequences of chronic sleep deprivation.</p></abstract><trans-abstract xml:lang="ru"><p>Хроническое недосыпание (сон менее 6 ч в сутки) в связи с производственной необходимостью и снижением качества сна является эндемическим заболеванием в современном обществе. Хроническое недосыпание вызывает серьезные нейроповеденческие нарушения, сопряженные с необратимыми нейродегенеративными изменениями в головном мозге. Поиск фармакологических агентов способных снизить риск развития нейродегенерации в результате хронической потери сна является актуальной задачей биомедицины. Интраназальное введение глюкозо-регулируемого белка теплового шока 78 кДа (GRP78) оказывает нейропротективный эффект в модели болезни Паркинсона у крыс. Нейропротективный потенциал интраназально введенного GRP78 при хроническом недосыпании ранее не исследовался. Задача исследования – выяснить, способно ли профилактическое интраназальное введение GRP78 ослабить и/или остановить процесс нейродегенерации в голубом пятне в модели хронического ограничения сна (ОС) у крыс. Исследование проведено на 6-месячных самцах крыс популяции Вистар. Для депривации сна был применен валидизированный метод качающейся платформы в режиме: 3 ч лишения сна и 1 ч покоя непрерывно в течение 5 суток. Рекомбинантный белок GRP78 человека вводили интраназально за два дня до начала ОС и в течение 5 суток ОС. Клеточно-молекулярные изменения в голубом пятне при ОС и при введении GRP78 исследовались с помощью иммуногистохимии и вестерн-блоттинга. Показано, что хроническое ОС приводит к гибели 30% норадренергических нейронов в голубом пятне, которое было сопряжено с повышением уровней активированных каспаз-3, 9. Это свидетельствует о развитии апоптоза по митохондриальному пути. Признаков реактивного микроглиоза не обнаружено в модели хронического ОС у крыс. Мы продемонстрировали, что интраназально введенный GRP78 проникает и накапливается в норадренергических нейронах голубого пятна, это противодействует гибели нейронов по пути апоптоза. Полученные данные позволяют считать GRP78 потенциальным нейропротекторным средством для профилактики патологических последствий хронического недосыпания.</p></trans-abstract><kwd-group xml:lang="en"><kwd>chronic sleep restriction</kwd><kwd>locus coeruleus</kwd><kwd>chaperone GRP78</kwd><kwd>HSPA5</kwd><kwd>neurodegeneration</kwd><kwd>apoptosis</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>хроническое ограничение сна</kwd><kwd>голубое пятно</kwd><kwd>шаперон GRP78</kwd><kwd>HSPA5</kwd><kwd>нейродегенерация</kwd><kwd>апоптоз</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution xml:lang="ru">Министерство науки и высшего образования Российской Федерации</institution></institution-wrap><institution-wrap><institution xml:lang="en">Ministry of Science and Higher Education of the Russian Federation</institution></institution-wrap></funding-source><award-id>075–15–2022–296</award-id></award-group></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Riemann D, Nissen C, Palagini L, Otte A, Perlis ML, Spiegelhalder K (2015) The neurobiology, investigation, and treatment of chronic insomnia. Lancet Neurol 14: 547–558. https://doi.org/10.1016/S1474–4422(15)00021–6</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Strygin KN, Poluektov MG (2017) INSOMNIA. Medical Council 52–58. https://doi.org/10.21518/2079–701X-2017–0–52–58</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Schutte-Rodin S, Broch L, Buysse D, Dorsey C, Sateia M (2008) Clinical guideline for the evaluation and management of chronic insomnia in adults. J Clin Sleep Med 04: 487–504. https://doi.org/10.5664/jcsm.27286</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Shan W, Peng X, Tan W, Zhou Z, Xie H, Wang S (2024) Prevalence of insomnia and associations with depression, anxiety among adults in guangdong, China: A large-scale cross-sectional study. Sleep Med 115: 39–47. https://doi.org/10.1016/j.sleep.2024.01.023</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ahn E, Baek Y, Park J-E, Lee S, Jin H-J (2024) Elevated prevalence and treatment of sleep disorders from 2011 to 2020: a nationwide population-based retrospective cohort study in Korea. BMJ Open 14: e075809. https://doi.org/10.1136/bmjopen-2023–075809</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Hisler G, Muranovic D, Krizan Z (2019) Changes in sleep difficulties among the U.S. population from 2013 to 2017: results from the National Health Interview Survey. Sleep Health 5: 615–620. https://doi.org/10.1016/j.sleh.2019.08.008</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Norell-Clarke A, Hagquist C (2017) Changes in sleep habits between 1985 and 2013 among children and adolescents in Sweden. Scand J Public Health 45: 869–877. https://doi.org/10.1177/1403494817732269</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Costa A, Pereira T (2019) The effects of sleep deprivation on cognitive performance. Eur J Public Health 29: ckz034.096. https://doi.org/10.1093/eurpub/ckz034.096</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Al-Abri M (2015) Sleep deprivation and depression: A bi-directional association. Sultan Qaboos Univ Med J 15: e4-e6.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Rosen I, Gimotty P, Shea J, Bellini L (2006) Evolution of sleep quantity, sleep deprivation, mood disturbances, empathy, and burnout among interns. Acad Med 81: 82–85. https://doi.org/10.1097/00001888–200601000–00020</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Belenky G, Wesensten N, Thorne D, Thomas M, Sing H, Redmond D, Russo M, Balkin T (2003) Patterns of performance degradation and restoration during sleep restriction and subsequent recovery: a sleep dose‐response study. J Sleep Res 12: 1–12. https://doi.org/10.1046/j.1365–2869.2003.00337.x</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Pejovic S, Basta M, Vgontzas A, Kritikou I, Shaffer M, Tsaoussoglou M, Stiffler D, Stefanakis Z, Bixler E, Chrousos G (2013) Effects of recovery sleep after one work week of mild sleep restriction on interleukin-6 and cortisol secretion and daytime sleepiness and performance. Am J Physiol Endocrinol Metab 305: E890-E896. https://doi.org/10.1152/ajpendo.00301.2013</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Van Dongen H, Maislin G, Mullington J, Dinges D (2003) The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep 26: 117–126. https://doi.org/10.1093/sleep/26.2.117</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Lutsey P, Misialek J, Mosley T, Gottesman R, Punjabi N, Shahar E, MacLehose R, Ogilvie R, Knopman D, Alonso A (2018) Sleep characteristics and risk of dementia and Alzheimer’s disease: The atherosclerosis risk in communities study. Alzheimers Dement 14: 157–166. https://doi.org/10.1016/j.jalz.2017.06.2269</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Pase M, Himali J, Grima N, Beiser A, Satizabal C, Aparicio H, Thomas R, Gottlieb D, Auerbach S, Seshadri S (2017) Sleep architecture and the risk of incident dementia in the community. Neurology 89: 1244–1250. https://doi.org/10.1212/WNL.0000000000004373</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Owen J, Zhu Y, Fenik P, Zhan G, Bell P, Liu C, Veasey S (2021) Late-in-life neurodegeneration after chronic sleep loss in young adult mice. Sleep 44(8): zsab057. https://doi.org/10.1093/sleep/zsab057</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Zhu Y, Fenik P, Zhan G, Somach R, Xin R, Veasey S (2016) Intermittent short sleep results in lasting sleep wake disturbances and degeneration of locus coeruleus and orexinergic neurons. Sleep 39: 1601–1611. https://doi.org/10.5665/sleep.6030</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Zhang J, Zhu Y, Zhan G, Fenik P, Panossian L, Wang M, Reid S, Lai D, Davis J, Baur J, Veasey S (2014) Extended wakefulness: compromised metabolics in and degeneration of locus coeruleus neurons. J Neurosci 34: 4418–4431. https://doi.org/10.1523/JNEUROSCI.5025–12.2014</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Aston-Jones G, Bloom F (1981) Activity of norepinephrine-containing locus coeruleus neurons in behaving rats anticipates fluctuations in the sleep-waking cycle. J Neurosci 1: 876–886. https://doi.org/10.1523/JNEUROSCI.01–08–00876.1981</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Benington J, Craig Heller H (1995) Restoration of brain energy metabolism as the function of sleep. Prog Neurobiol 45: 347–360. https://doi.org/10.1016/0301–0082(94)00057-O</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Costa C, Manaa W, Duplan E, Checler F (2020) The endoplasmic reticulum stress/unfolded protein response and their contributions to Parkinson’s disease physiopathology. Cells 9: 2495. https://doi.org/10.3390/cells9112495</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Naidoo N, Giang W, Galante R, Pack A (2005) Sleep deprivation induces the unfolded protein response in mouse cerebral cortex. J Neurochem 92: 1150–1157. https://doi.org/10.1111/j.1471–4159.2004.02952.x</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Voronin MV, Abramova EV, Verbovaya ER, Vakhitova YV, Seredenin SB (2023) Chaperone-dependent mechanisms as a pharmacological target for neuroprotection. Int J Mol Sci 24: 823. https://doi.org/10.3390/ijms24010823</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Gorbatyuk M, Gorbatyuk O (2013) The molecular chaperone GRP78/BiP as a therapeutic target for neurodegenerative disorders: A mini review. J Genet Syndr Gene Ther 4. https://doi.org/10.4172/2157–7412.1000128</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Pazi M, Belan D, Komarova E, Ekimova I (2024) Intranasal administration of GRP78 protein (HSPA5) confers neuroprotection in a lactacystin-induced rat model of parkinson’s disease. Int J Mol Sci 25: 3951. https://doi.org/10.3390/ijms25073951</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Guzeev MA, Kurmazov NS, Simonova VV, Pastukhov YuF, Ekimova IV (2021) Modeling of chronic sleep restriction for translational studies. SS Korsakov J Neurol Psychiatr 121(4–2): 6–13. https://doi.org/10.17116/jnevro20211214026</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Paxinos G, Watson C (2007) The rat brain in stereotaxic coordinates. 6th ed. Elsevier. Amsterdam.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Manchanda S, Singh H, Kaur T, Kaur G (2018) Low-grade neuroinflammation due to chronic sleep deprivation results in anxiety and learning and memory impairments. Mol Cell Biochem 449: 63–72. https://doi.org/10.1007/s11010–018–3343–7</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Hurtado-Alvarado G, Domínguez-Salazar E, Pavon L, Velázquez-Moctezuma J, Gómez-González B (2016) Blood-brain barrier disruption induced by chronic sleep loss: Low-grade inflammation may be the link. J Immunol Res 2016: 1–15. https://doi.org/10.1155/2016/4576012</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Deurveilher S, Semba K (2019) Physiological and neurobehavioral consequences of chronic sleep sestriction in rodent models. Handbook Sleep Res 557–567. https://doi.org/10.1016/B978–0–12–813743–7.00037–2</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Deurveilher S, Rusak B, Semba K (2012) Time-of-day modulation of homeostatic and allostatic sleep responses to chronic sleep restriction in rats. Am J Physiol Regul Integr Comp Physiol 302(12): R1411-R1425. https://doi.org/10.1152/ajpregu.00678.2011</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Takemoto H, Yoshimori T, Yamamoto A, Miyata Y, Yahara I, Inoue K, Tashiro Y (1992) Heavy chain binding protein (BiP/GRP78) and endoplasmin are exported from the endoplasmic reticulum in rat exocrine pancreatic cells, similar to protein disulfide-isomerase. Arch Biochem Biophys 296: 129–136. https://doi.org/10.1016/0003–9861(92)90554-A</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Baek J-H, Mamula D, Tingstam B, Pereira M, He Y, Svenningsson P (2019) GRP78 level is altered in the brain, but not in plasma or cerebrospinal fluid in Parkinson’s disease patients. Front Neurosci 13: 697. https://doi.org/10.3389/fnins.2019.00697</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Casas C (2017) GRP78 at the centre of the stage in cancer and neuroprotection. Front Neurosci 11: 177. https://doi.org/10.3389/fnins.2017.00177</mixed-citation></ref><ref id="B35"><label>35.</label><mixed-citation>Shields A, Thompson S, Panayi G, Corrigall V (2012) Pro-resolution immunological networks: binding immunoglobulin protein and other resolution-associated molecular patterns. Rheumatology (Oxford) 51: 780–788. https://doi.org/10.1093/rheumatology/ker412</mixed-citation></ref><ref id="B36"><label>36.</label><mixed-citation>Eggleton P, De Alba J, Weinreich M, Calias P, Foulkes R, Corrigall V (2023) The therapeutic mavericks: Potent immunomodulating chaperones capable of treating human diseases. J Cell Mol Med 27: 322–339. https://doi.org/10.1111/jcmm.17669</mixed-citation></ref><ref id="B37"><label>37.</label><mixed-citation>Zhu Y, Fenik P, Zhan G, Mazza E, Kelz M, Aston-Jones G, Veasey S (2007) Selective loss of catecholaminergic wake–active neurons in a murine sleep apnea model. J Neurosci 27: 10060–10071. https://doi.org/10.1523/JNEUROSCI.0857–07.2007</mixed-citation></ref><ref id="B38"><label>38.</label><mixed-citation>Somarajan B, Khanday M, Mallick B (2016) Rapid eye movement sleep deprivation induces neuronal apoptosis by noradrenaline acting on alpha1 adrenoceptor and by triggering mitochondrial intrinsic pathway. Front Neurol 7: 25. https://doi.org/10.3389/fneur.2016.00025</mixed-citation></ref><ref id="B39"><label>39.</label><mixed-citation>Leiva-Rodríguez T, Romeo-Guitart D, Herrando-Grabulosa M, Muñoz-Guardiola P, Polo M, Bañuls C, Petegnief V, Bosch A, Lizcano J, Apostolova N, Forés J, Casas C (2021) GRP78 Overexpression triggers PINK1-IP3R-mediated neuroprotective mitophagy. Biomedicines 9: 1039. https://doi.org/10.3390/biomedicines9081039</mixed-citation></ref><ref id="B40"><label>40.</label><mixed-citation>Bellesi M, de Vivo L, Chini M, Gilli F, Tononi G, Cirelli C (2017) Sleep loss promotes astrocytic phagocytosis and microglial activation in mouse cerebral cortex. J Neurosci 37: 5263–5273. https://doi.org/10.1523/JNEUROSCI.3981–16.2017</mixed-citation></ref><ref id="B41"><label>41.</label><mixed-citation>Wadhwa M, Kumari P, Chauhan G, Roy K, Alam S, Kishore K, Ray K, Panjwani U (2017) Sleep deprivation induces spatial memory impairment by altered hippocampus neuroinflammatory responses and glial cells activation in rats. J Neuroimmunol 312: 38–48. https://doi.org/10.1016/j.jneuroim.2017.09.003</mixed-citation></ref><ref id="B42"><label>42.</label><mixed-citation>Hall S, Deurveilher S, Robertson G, Semba K (2020) Homeostatic state of microglia in a rat model of chronic sleep restriction. Sleep 43(11): zsaa108. https://doi.org/10.1093/sleep/zsaa108</mixed-citation></ref><ref id="B43"><label>43.</label><mixed-citation>Hou J, Shen Q, Wan X, Zhao B, Wu Y, Xia Z (2019) REM sleep deprivation-induced circadian clock gene abnormalities participate in hippocampal-dependent memory impairment by enhancing inflammation in rats undergoing sevoflurane inhalation. Behav Brain Res 364: 167–176. https://doi.org/10.1016/j.bbr.2019.01.038</mixed-citation></ref><ref id="B44"><label>44.</label><mixed-citation>Xie L, Kang H, Xu Q, Chen M, Liao Y, Thiyagarajan M, O’Donnell J, Christensen D, Nicholson C, Iliff J, Takano T, Deane R, Nedergaard M (2013) Sleep drives metabolite clearance from the adult brain. Science 342: 373–377. https://doi.org/10.1126/science.1241224</mixed-citation></ref><ref id="B45"><label>45.</label><mixed-citation>Lapshina KV, Ekimova IV (2024) Aquaporin-4 and Parkinson’s Disease. Int J Mol Sci 25: 1672. https://doi.org/10.3390/ijms25031672</mixed-citation></ref><ref id="B46"><label>46.</label><mixed-citation>Shokri-Kojori E, Wang G-J, Wiers C, Demiral S, Guo M, Kim S, Lindgren E, Ramirez V, Zehra A, Freeman C, Miller G, Manza P, Srivastava T, De Santi S, Tomasi D, Benveniste H, Volkow N (2018) β-Amyloid accumulation in the human brain after one night of sleep deprivation. Proc Natl Acad Sci U S A 115: 4483–4488. https://doi.org/10.1073/pnas.1721694115</mixed-citation></ref><ref id="B47"><label>47.</label><mixed-citation>Ju Y-ES, Ooms S, Sutphen C, Macauley S, Zangrilli M, Jerome G, Fagan A, Mignot E, Zempel J, Claassen J, Holtzman D (2017) Slow wave sleep disruption increases cerebrospinal fluid amyloid-β levels. Brain 140: 2104–2111. https://doi.org/10.1093/brain/awx148</mixed-citation></ref><ref id="B48"><label>48.</label><mixed-citation>Lapshina KV, Guzeev MA, Ekimova IV (2016) Glucose-regulated protein Grp78 affects characteristics of sleep and thermoregulation in rats. J Evol Biochem Physiol 52: 161–167. https://doi.org/10.1134/S002209301602006X</mixed-citation></ref><ref id="B49"><label>49.</label><mixed-citation>Naidoo N, Casiano V, Cater J, Zimmerman J, Pack A (2007) A role for the molecular chaperone protein BiP/GRP78 in drosophila sleep homeostasis. Sleep 30: 557–565. https://doi.org/10.1093/sleep/30.5.557</mixed-citation></ref></ref-list></back></article>
